Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Dispatch

Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022

Berta Suárez Rodríguez1, Bernardo R. Guzmán Herrador1Comments to Author , Asunción Díaz Franco, María Paz Sánchez-Seco Fariñas, Julia del Amo Valero, Adrián Hugo Aginagalde Llorente, Juan Pablo Alonso Pérez de Agreda, Rosa Carbó Malonda, Daniel Castrillejo, María Dolores Chirlaque López, Eduardo Javier Chong Chong, Sonia Fernández Balbuena, Virtudes Gallardo García, Manuel García-Cenoz, Laura García Hernández, Elisa Gil Montalbán, Fernando González Carril, Teresa González Cortijo, Susana Jiménez Bueno, Aurora Limia Sánchez, Juan Antonio Linares Dópido, Nicola Lorusso, Mario Margolles Martins, Eva María Martínez Ochoa, Ana Martínez Mateo, Jacobo Mendioroz Peña, Ana Isabel Negredo Antón, María Teresa Otero Barrós, Maria del Carmen Pacheco Martinez, Pilar Peces Jiménez, Oscar-Guillermo Pérez Martín, Ana Isabel Rivas Pérez, María Sastre García, National Monkeypox Response Group2, Fernando Simón Soria3, and María José Sierra Moros3
Author affiliations: Coordinating Centre for Health Alerts and Emergencies, Directorate General of Public Health, Ministry of Health, Madrid, Spain (B. Suarez Rodriguez, B.R. Guzmán Herrador, E.J. Chong Chong, S. Fernández Balbuena, F. Simón Soria, M.J. Sierra Moros); National Centre of Epidemiology, Carlos III Health Institute, Madrid (A. Díaz Franco, M. Sastre García); National Centre for Microbiology, Instituto de Salud Carlos III, Madrid (M.P. Sánchez-Seco Fariñas, A. I. Negredo Antón); Division for HIV Control, STI, Viral Hepatitis and Tuberculosis, Ministry of Health, Madrid (J. del Amo Valero); Public Health Observatory of Cantabria, Cantabria, Spain (A.H. Aginagalde Llorente); Dirección General de Salud Pública, Aragón, Spain (J.P. Alonso Pérez de Agreda); Subdirecció General d’Epidemiologia, Vigilància de la Salut i Sanitat Ambiental, Comunidad Valenciana, Spain (R. Carbó Malonda); Consejería de Políticas Sociales, Salud Pública y Bienestar Animal, Melilla, Spain (D. Castrillejo); Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain (M.D. Chirlaque López); Ministry of Health and Families of Andalusia, Andalusia, Spain (V. Gallardo García, N Lorusso); Instituto de Salud Pública de Navarra, Spain and Navarre Institute for Health Research (IdiSNA), Pamplona, Spain (M. García-Cenoz); Dirección General de Salud Pública del Servicio Canario de la Salud, Tenerife, Spain (L. García Hernández, O.-G. Pérez Martín); Dirección General de Salud Pública de la Comunidad de Madrid, Madrid (E. Gil Montalbán, S. Jiménez Bueno); Departamento de Salud del País, Vasco, Spain (F. González Carril); Dirección General de Salud Pública, Islas Baleares, Spain (T. González Cortijo); Immunization Programme Area, Directorate General of Public Health, Ministry of Health, Madrid (A. Limia Sánchez); Dirección General de Salud Pública. Servicio Extremeño de Salud, Merida, Spain (J.A. Linares Dópido); Dirección General de Salud Pública. Gobierno de Asturias, Oviedo, Spain (M. Margolles Martins); Dirección General de Salud Pública, Consumo y Cuidados de la Consejería de Salud de La Rioja, Logroño, Spain (E.M. Martínez Ochoa); Public Health Agency of Catalonia, Barcelona, Spain (A. Martinez Mateo, J. Mendioroz Peña); Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Santiago, Spain (M.T. Otero Barrós); Dirección General de Salud Pública, Castilla y León, Valladolid, Spain (M.C. Pacheco Martinez); Servicio de Epidemiología, Castilla-La Mancha, Toledo, Spain (P. Peces Jiménez); Consejería de Sanidad, Consumo y Gobernación. Ciudad Autónoma de Ceuta, Ceuta, Spain (A.I. Rivas Pérez); CIBER in Infectious Diseases, Madrid, CIBERINFEC (M.P. Sánchez-Seco Fariñas, A.I. Negredo Antón, M.J. Sierra Moros, A. Díaz Franco); CIBER in Epidemiology and Public Health, Madrid, CIBERESP (M.D. Chirlaque López, M. García-Cenoz, A. Martinez Mateo, M. Sastre García, F. Simón Soria)

Main Article

Figure

Epidemic plot of 1,182 confirmed cases of monkeypox according to date of onset of symptoms for late April, May, and June 2022, Spain. April cases were reported during April 25–30. Cases without date of symptom onset were not included (for 72 male case-patients and 2 female case-patients).

Figure. Epidemic plot of 1,182 confirmed cases of monkeypox according to date of onset of symptoms for late April, May, and June 2022, Spain. April cases were reported during April 25–30. Cases without date of symptom onset were not included (for 72 male case-patients and 2 female case-patients).

Main Article

1These first authors contributed equally to this article.

2Members of this group are listed at the end of this article.

3These senior authors contributed equally to this article.

Page created: July 09, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external